Combined antioxidant carotenoids and the risk of persistent human papillomavirus infection

Nutrition and Cancer

Volumn 62, Issue 6, 2010, Pages 728-733

  Peterson, Caryn E ^a   Sedjo, Rebecca L ^b   Davis, Faith G ^a   Beam, Craig A ^c   Giuliano, Anna R ^d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ALPHA CRYPTOXANTHIN; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; CIS BETA CAROTENE; CIS LYCOPENE; CRYPTOXANTHIN; LYCOPENE; TRANS LYCOPENE; UNCLASSIFIED DRUG; XANTHOPHYLL; ZEAXANTHIN;

ADULT; ARTICLE; CONFIDENCE INTERVAL; DIETARY INTAKE; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NUTRIENT; PERSISTENT INFECTION; PROSPECTIVE STUDY; VERRUCA VULGARIS; WART VIRUS;

ADOLESCENT; ADULT; ANTIOXIDANTS; CAROTENOIDS; FEMALE; HUMANS; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; RISK;

HUMAN PAPILLOMAVIRUS;

EID: 77954977193     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003693074     Document Type: Article

References (24)

1. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, et al.: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327, 1272-1278, 1992.
2. Nobbenhuis MA, Marielle AE, Walboomers JM, Helmerhorst TJ, Rozendaal L, et al.: Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354, 20-25, 1999.
3. Mitchell MF, Tortolero-Luna G, Wright T, Sarkar A, Richards-Kortum R, et al.: Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr 21, 17-25, 1996.
4. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M,et al.: Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286, 3106-3114, 2001.
5. Bosch FX, MunozN, deSanjoseS, et al.: Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 52, 750-758, 1992.
6. Au WW, Sierra-Torres CH, and Tyring SK: Acquired and genetic susceptibility to cervical cancer. Mutat Res 544, 361-364, 2003.
7. LaVecchiaC, Franceschi S, DeCarliA, FasoliM, Gentile A,and Tognoni G: Cigarette smoking and the risk of cervical neoplasia. Am J Epidemiol 123, 22-29, 1986.
8. Matos A, Moutinho J, Pinto D, and Medeiros R: The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population. Eur J Cancer Prev 14, 485-491, 2005.
9. Kjellberg L, Hallmans G, AhrenAM, Johansson R, Bergman F, et al.: Smoking, diet, pregnancy, and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 82, 1332-1338, 2000.
10. Hellberg D and Stendahl U: The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer. Anticancer Res 25, 3041-3046, 2005.
11. Castellsague X and Munoz N: Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31, 20-28, 2003.
12. Castle PE and Giuliano AR: Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr 31, 29-34, 2003.
13. Giuliano AR, SiegelEM, RoeDJ, FerreiraS, BaggioML, et al.: Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study. J Infect Dis 188, 1508-1516, 2003.
14. Giuliano AR, Papenfuss M, NourM, et al.: Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 6, 917-923, 1997.
15. Sedjo RL, Roe DJ, Abrahamsen M, Harris RB, Craft N, et al. Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 11, 876-884, 2002.
16. Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, et al.: Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis 186, 462-469, 2002.
17. Sedjo RL, Inserra P, Abrahamsen M, et al.: Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev 11, 353-359, 2002.
18. BlockG, HartmanAM, DresserCM, CarrollMD, GannonJ,and Gardner L: A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124, 453-469, 1986.
19. Thomson CA, Giuliano AR, Grover E, et al.: Reproducibility and Validity of the Arizona Cancer Center Food Frequency Questionnaire (AFFQ) Among Whel Cohort Participants. In: 25th Annual ASPO Meeting. New York, 2001.
20. Martinez ME, Marshall JR, Graver E, et al.: Reliability and validity of a self-administered food frequency questionnaire in a chemoprevention trial of adenoma recurrence. Cancer Epidemiol Biomarkers Prev 8, 941-946, 1999.
21. Craft N: High resolution HPLC method for the simultaneous analysis of carotenoids, retinoids, tocoperols. FASB J A527, 1996.
22. Di Mascio P, Murphy ME, and Sies H: Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr 53(1Suppl), 194S-200S, 1991.
23. Siegel EM, Craft NE, Duarte-Franco E, et al.: Associations between serum carotenoids and tocopherols and type-specific HPV persistence: the Ludwig-McGill cohort study. Int J Cancer 120, 672-680, 2007.
24. Sedjo RL, Papenfuss MR, Craft NE, and Giuliano AR: Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States). Cancer Causes Control 14, 319-326, 2003.